Musculoskeletal Research Unit, School of Translational Health Sciences, Southmead Hospital, University of Bristol, Bristol, UK.
College of Engineering, Mathematics and Physical Sciences, University of Exeter, Exeter, UK.
Rheumatology (Oxford). 2019 May 1;58(5):831-835. doi: 10.1093/rheumatology/key374.
To evaluate determinants of discordance between DAS28-ESR and DAS28-CRP and resulting impact on disease activity stratification in RA.
Paired DAS28-ESR and DAS28-CRP readings (n = 31 074) were obtained from the British Society for Rheumatology Biologics Register for RA. Factors influencing discordance between DAS28-ESR and DAS28-CRP were evaluated alongside the resulting effect on disease activity stratification. The impact of gender adjustment to the DAS28-CRP was evaluated.
DAS28-CRP scores were ∼0.3 lower than DAS28-ESR overall, with greatest differences for women (-0.35) and patients over 50 years old (-0.34). Mean male DAS28-CRP scores were 0.15 less than corresponding DAS28-ESR scores. Discordance between DAS28-ESR and DAS28-CRP significantly impacted disease activity stratification at low disease activity and remission thresholds (32.0% and 66.6% concordance, respectively). Adjusting DAS28-CRP scores by gender significantly (P < 0.001) improved agreement with the DAS28-ESR.
Discordance between DAS28-ESR and DAS28-CRP is greatest for women and patients over 50 years of age, and influences disease activity stratification. The proposed gender-adjusted DAS28-CRP improves inter-score agreement with DAS28-ESR, supporting more reliable disease activity stratification in treat-to-target approaches for RA.
评估 DAS28-ESR 和 DAS28-CRP 之间差异的决定因素及其对 RA 疾病活动分层的影响。
从英国风湿病学会生物制剂登记处 RA 中获得了配对的 DAS28-ESR 和 DAS28-CRP 读数(n=31074)。评估了影响 DAS28-ESR 和 DAS28-CRP 之间差异的因素,以及对疾病活动分层的影响。还评估了对 DAS28-CRP 进行性别调整的影响。
总体而言,DAS28-CRP 评分比 DAS28-ESR 低约 0.3,女性(-0.35)和 50 岁以上患者(-0.34)的差异最大。男性 DAS28-CRP 评分的平均水平比相应的 DAS28-ESR 评分低 0.15。DAS28-ESR 和 DAS28-CRP 之间的差异显著影响低疾病活动和缓解阈值的疾病活动分层(分别为 32.0%和 66.6%的一致性)。通过性别调整 DAS28-CRP 评分显著(P<0.001)提高了与 DAS28-ESR 的一致性。
DAS28-ESR 和 DAS28-CRP 之间的差异在女性和 50 岁以上患者中最大,并且影响疾病活动分层。建议的性别调整 DAS28-CRP 提高了与 DAS28-ESR 的评分一致性,支持 RA 靶向治疗方法中更可靠的疾病活动分层。